$NKTR UPDATE: Brean Capital Raises Nektar Price Target To $20 On The Heels Of FDA Approval Of Movantik http://www.smarteranalyst.com/2014/09/16/update-brean-capital-raises-nektar-price-target-to-20-on-the-heels-of-fda-approval-of-movantik/